S. 4875: PASTEUR Act of 2026

S. 4875 is a federal bill in the 119th Congress. Today, pharmaceutical companies have little financial incentive to develop new antibiotics because these drugs are typically used sparingly and for short durations, yielding low sales compared to chronic disease medications. Under this bill, the federal… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.